JAK2 mutation and thrombosis in the myeloproliferative neoplasms. [electronic resource]
- Current hematologic malignancy reports Jan 2010
- 22-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-822X
10.1007/s11899-009-0038-x doi
Amino Acid Substitution Aspirin--therapeutic use Cardiovascular Diseases--epidemiology Clinical Trials as Topic Fibrinolytic Agents--therapeutic use Humans Incidence Interferon-alpha--therapeutic use Janus Kinase 2--genetics Multicenter Studies as Topic Mutation, Missense Myeloproliferative Disorders--blood Phenotype Point Mutation Quinazolines--therapeutic use Thrombophilia--enzymology Thrombosis--epidemiology